Skip to main content
. 2022 Aug 30;10(9):1427. doi: 10.3390/vaccines10091427

Table 3.

GMT of SARS-CoV-2 S glycoprotein-specific antibody.

Low Dose (0.2 mg) High Dose (0.4 mg)
N = 10 N = 10
GMT [95% CI] GMT [95% CI]
Week 0 200 [-, -] 324.9 [182.8, 577.4]
Week 2 (day 28) 200 [-, -] 303.1 [187.8, 489.4]
Week 4 (day 56) 200 [-, -] 324.9 [182.8, 577.4]
Week 6 (day 84) 200 [-, -] 324.9 [182.8, 577.4]
Week 8 (day 112) 246.2 [176.2, 344.1] 348.2 [181.3, 668.9]
Week 12 (day 140) 229.7 [167.9, 314.4] 303.1 [177.9, 516.6]
Week 20 (day 196) 200 [-, -] 200 [-, -] (N = 9)
Week 24 (day 224) 214.4 [183.2, 250.7] 252.0 [147.9, 429.3] (N = 9)